Pazianas, Michael <br/><br/>
Commentary: drug-associated atypical femoral fractures (DaAFFs): balancing the facts.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Jul 2014 
 - 2340-2 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2014-1375  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bone Density Conservation Agents--adverse effects<br/>Bone Neoplasms--complications<br/>Denosumab<br/>Diphosphonates--adverse effects<br/>Drug Utilization<br/>Femoral Fractures--chemically induced<br/>Humans<br/>Neoplasms--drug therapy<br/>Osteonecrosis--chemically induced<br/>Osteoporosis, Postmenopausal--drug therapy